G50R (p.Gly50Arg) variant of OTC (P00480)

G50R (p.Gly50Arg) in OTC (P00480) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Ornithine carbamoyltransferase deficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.57 / 1. The record also includes population frequency data, published literature, and structural context.

G50R (p.Gly50Arg) variant details